Facing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...

India's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...

A Himachal Pradesh government drug laboratory has declared two batches of an imported peritoneal dialysis solution “Not of Standard Quality...

Biocon shares rose after a block deal involving around 1.65 crore shares. Investor Active Pine was reportedly looking to sell up to 1.66 cr...

Private equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...

Active Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development...

Piyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...

The Indian market was under pressure on Thursday, particularly at the index level. Rising crude-oil prices are an obvious concern, but dome...

The commerce ministry of India is actively soliciting feedback from exporters about challenges in accessing the US market. Minister Piyush ...

Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...

India's Commerce Ministry will meet industry leaders on September 1 regarding trade performance. This meeting precedes Minister Piyush Goya...

Brazilian Foreign Minister Mauro Vieira has described Brazil, South Africa and India as major democratic partners of the Global South, stre...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

US tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...

For the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...